Print this page
Tuesday, 17 May 2016 07:53

Recall On Batches Of Cinnarizine Tablet 25mg

Rate this item
(0 votes)

The Agency has been notified of the recall of four batches of Cinnarizine Tablet 25mg by the manufacturer, Industrial Fermaceutica Nova Argentia Spa, Italy. The recall is as a result of received complaints about black spots found on certain Cinnarizine tablets. The black spots were suspected to be foreign matter including plastic fragments and lubricant. The Italian manufacturer decided to recall four affected batches from the market after preliminary investigation.

Cinnarizine is an over-the-counter medication used in the treatment of motion sickness, nausea and vomiting.

Product details

  • Manufacturer: Industrial Fermaceutica Nova Argentia Spa, Italy.
  • Drug name: Cinnarizine tablets 25mg
  • Registration number: HK-12005
  • Batch numbers: M40594/1, M40594/2, 150282/1 and 150282/2

Healthcare Provider/Patient’s action

  • Healthcare providers should desist from administering Cinnarizine that fits the above specifications to patients.
  • Report all serious adverse events or side effects related to the use of these drug products to NAFDAC PRASCOR (20543 – Toll free from all network) or via adverse events report forms or to This email address is being protected from spambots. You need JavaScript enabled to view it.

NAFDAC… Safeguarding the health of the Nation!!!

Read 6567 times Last modified on Tuesday, 17 May 2016 08:01